Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
TAK063 CAS:1238697-26-1
TAK063
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1130 | 100mg | 425.00 | + Add to cart |
|
| R-C-1130 | 200mg | 710.00 | + Add to cart |
|
| R-C-1130 | 500mg | 1305.00 | + Add to cart |
|
|
|
||||
Product description
TAK-063,also known as Balipodect.,is a highly potent,selective,and orally active phosphodiesterase 10A(PDE10A)inhibitor.TAK-063 is currently being evaluated in clinical trials for the treatment of schizophrenia. Phosphodiesterase 10A(PDE10A)is a cAMP/cGMP phosphodiesterase highly expressed in medium spiny neurons(MSNs)in the striatum.TAK-063 represents a promising drug for the treatment of schizophrenia with potential for superior safety and tolerability profiles.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---TAK063 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
